Market-leading microRNA Research Solutions
To enable discovery of new biology and new biomarkers
MiRXES microRNA detection suite
Our patented ID3EAL quantitative reverse transcription polymerase chain reaction (RT-qPCR) technology platform enables sensitive, specific, and robust detection of microRNA and other RNAs in biofluid and tissue samples.
The ID3EAL way to microRNA discoveries
Join our global user network
Enable discoveries with MiRXES ID3EAL microRNA research solutions.
Select from a growing library of validated human, mouse, rat, and viral microRNA assays.
Available worldwide through our distributors.
Collaborate with us
Collaborate directly with MiRXES Lab for a one-stop, comprehensive microRNA profiling and biomarker discovery solution in our dedicated high throughput microRNA profiling laboratories.
Collaborate with one of our partner non-coding RNA core facilities located at top academic institutions in Singapore and Boston, USA.
The MiRXES advantage
Our ID3EAL RT-qPCR solution has been independently validated to be more sensitive than other RT-qPCR technology platforms for microRNA quantification.
Deep expertise and experience
Discovering and validating microRNA biomarkers since 2012.
We have curated the world's largest clinical microRNA expression database, with over 40,000 samples covering more than 30 disease types.
We have a track record of top-tier scientific publications and research collaborations with top institutions and scientific experts worldwide.
World-class research capabilities
Our core R&D lab can complete 200,000 qPCR reactions a day for high-throughput biomarker discovery.
Ready for best-in-class microRNA detection?
MiRXES is committed to advancing innovative molecular diagnostics for preventive healthcare and precision medicine. Contact us to find out how our class-leading technology and world-class capabilities can benefit you!